A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

NCT05819112 · clinicaltrials.gov ↗
TERMINATED
Status
14799
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor's decision. Termination decision unrelated to safety profile.

Conditions

Sponsor

Sanofi